Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Fredrik Åberg, Jaana Helenius‐Hietala, Pauli Puukka, et al.
Hepatology (2017) Vol. 67, Iss. 6, pp. 2141-2149
Closed Access | Times Cited: 220

Showing 26-50 of 220 citing articles:

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 51
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 31
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Hannes Hagström, Ying Shang, Hannes Hegmar, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 10, pp. 944-956
Closed Access | Times Cited: 30
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
David Martí‐Aguado, José Luís Calleja, Eduardo Vilar‐Gómez, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 930-940
Closed Access | Times Cited: 28
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Patrik Nasr, Axel Wester, Mattias Ekstedt, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 5, pp. 1048-1057.e2
Open Access | Times Cited: 21
Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities
Michelle Yi, L Cisneros, E.J. Cho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 821-821
Open Access | Times Cited: 16
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease
Katrine Thorhauge, Georg Semmler, Stine Johansen, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 1, pp. 23-32
Open Access | Times Cited: 15
Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow‐Up of Population Cohorts
Fredrik Åberg, Pauli Puukka, Veikko Salomaa, et al.
Hepatology (2019) Vol. 71, Iss. 3, pp. 835-848
Closed Access | Times Cited: 140
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
Juan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares‐da‐Silva, et al.
Annals of Hepatology (2020) Vol. 19, Iss. 6, pp. 674-690
Open Access | Times Cited: 109
Toward More Accurate Nomenclature for Fatty Liver Diseases
Mohammed Eslam, Arun J. Sanyal, Jacob George
Gastroenterology (2019) Vol. 157, Iss. 3, pp. 590-593
Open Access | Times Cited: 107
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Francisco Idalsoaga, Anand V. Kulkarni, Omar Y. Mousa, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 99
Alcohol‐Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study†
Gyöngyi Szabó, Patrick S. Kamath, Vijay H. Shah, et al.
Hepatology (2019) Vol. 69, Iss. 5, pp. 2271-2283
Open Access | Times Cited: 97
Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study
Mark Thursz, Patrick S. Kamath, Philippe Mathurin, et al.
Journal of Hepatology (2019) Vol. 70, Iss. 3, pp. 521-530
Open Access | Times Cited: 89
The Effect of Nutrition on Aging—A Systematic Review Focusing on Aging-Related Biomarkers
Catarina Leitão, Anna Mignano, Marta Estrela, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 554-554
Open Access | Times Cited: 57
Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches
Paola Dongiovanni, Erika Paolini, Alberto Corsini, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 7
Open Access | Times Cited: 56
Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score
Fredrik Åberg, Panu K. Luukkonen, Anna But, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 302-311
Open Access | Times Cited: 48
Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis
Xuanxuan Niu, Lin Zhu, Yifan Xu, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Current Medical Treatment for Alcohol-Associated Liver Disease
Gustavo Ayares, Francisco Idalsoaga, Luis Antonio Díaz, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 12, Iss. 5, pp. 1333-1348
Open Access | Times Cited: 37
Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
Stephen Malnick, Pavel Alin, Marina Somin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16226-16226
Open Access | Times Cited: 37
Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States
Samer Gawrieh, Eduardo Vilar‐Gómez, Tinsay A. Woreta, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 59, Iss. 5, pp. 666-679
Closed Access | Times Cited: 24
Management of alcohol use disorder in patients with chronic liver disease
Jessica L. Mellinger, Anne C. Fernandez, Gerald Scott Winder
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 23
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
Hannes Hagström, Hannes Hegmar, Christophe Moreno
United European Gastroenterology Journal (2024) Vol. 12, Iss. 2, pp. 168-176
Open Access | Times Cited: 13
Alcohol-associated liver disease—Global epidemiology
Fredrik Åberg, Z. Gordon Jiang, Helena Cortez‐Pinto, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1307-1322
Closed Access | Times Cited: 13
Alcohol-associated liver cancer
Yaojie Fu, Luca Maccioni, Xin Wei Wang, et al.
Hepatology (2024) Vol. 80, Iss. 6, pp. 1462-1479
Closed Access | Times Cited: 9
Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria
Luis Antonio Díaz, Jeffrey V. Lazarus, Eduardo Fuentes‐López, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 8

Scroll to top